Bladder cancer is a relatively small indication for Trodelvy, representing less than 10% of the drug’s sales, Gilead’s CFO ...

A diagnosis of cancer can take a toll on more than a person's health. Researchers at Beth Israel Deaconess Medical Center and ...

Gilead in 2021 won the FDA accelerated nod for Trodelvy in metastatic urothelial cancer, but continued approval was contingent on the outcome of a confirmatory study. The company in late May said that ...

There is a role for both payers and providers to make small changes that would increase the use of biomarker testing to ensure patients are receiving the appropriate treatment, said Susan Wescott, RPh ...

Dr. Kurdi received his Medical Degree with honors from The Faculty of Medicine of Damascus University. Dr. Kurdi also completed his residency at St. Joseph Mercy Hospital, Oakland, MI, a fellowship in ...